Clinical Trial Update: Study of Panitumumab-Capecitabine-Oxaliplatin In Wild-Type K-Ras Metastatic Colorectal Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the combination of panitumumab, capecitabine, and oxaliplatin in wild-type KRAS metastatic colorectal cancer. The trial status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Panitumumab (panitumumab)

Snippet

Sponsor: Hellenic Cooperative Oncology Group | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED